Despite the notable advancements in cancer pharmacotherapy, such as chemotherapy, targeted therapy, and immunotherapy, which have significantly improved patient survival rates, managing the associated ...
According to Cumberland Pharmaceuticals, the newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions by combining the first 2 ...